Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome

Condition:   Nephrotic Syndrome Interventions:   Drug: Rituximab Biosimilar ABP 798;   Drug: Daratumumab Sponsor:   Istituto Giannina Gaslini Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials